Where does Halozyme, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Halozyme, Inc. ranks #6,659 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Halozyme, Inc. hold?

Halozyme, Inc. holds 50 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Halozyme, Inc.'s Innovation Score?

Halozyme, Inc. has an Innovation Score of 53.6 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Halozyme, Inc. focus on?

Halozyme, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 47 patents, ranking #474 of 7,163 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Halozyme, Inc.'s patent grant rate increasing or decreasing?

Halozyme, Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Halozyme, Inc.'s patents?

Halozyme, Inc.'s patents average 29.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Halozyme, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Halozyme, Inc.

USPTO PatentsView assignee record - 50 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Halozyme ranks #6,659 of 49,997 tracked US assignees by granted-patent volume, with 50 patents across 8 technology areas.

#6,659
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.6/100): 29.3
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6659 · US Corporation #6,659 · 50 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 50 grants
UPPER-Q #6,659/49,997
PHOTO-FINISH Gauthier Biomedical
CPC-NARROW A61K · 8 areas
INNOV-PAR 53.6/100
CLAIMS-DENSE 29.3 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gauthier Biomedical, Inc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Halozyme’s 53.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.6 pts (25%) Velocity 15.0 pts (28%) Breadth 10.0 pts (19%) Claim depth 15.0 pts (28%)

Qualcomm Incorporated · highest

85
Advanced Micro-fabri… · near

54
Bayer Pharma… · near

54
Halozyme · this assignee

54
Heatcraft Refrigerat… · near

54
Oxylabs UAB · near

54
3D Lighting… · lowest

7

What this shows Halozyme's Innovation Score is 53.6/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Halozyme?

Each dot is one of Halozyme’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Halozyme’s own 29.3 claims/patent is ABOVE the 14.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Halozyme vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Halozyme's grants concentrate

Halozyme, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 94% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (15 grants) versus a trough of 1 in 2022. By volume, Halozyme sits between Gustav Klauke GMBH and Hyper Ice, Inc..

Halozyme's three-year grant acceleration

Halozyme, Inc. shows 18 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Gustav Klauke

50
Gyrfalcon Technol…

50
Gauthier Biomedic…

50
Guidewire Software

50
Hitachi Industry…

50
Hoffman Enclosures

50
Humanetics

50
Hyper Ice

50
Halozyme ◀

50

What this shows Halozyme holds 50 patents at rank #6,659, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Halozyme

By rank, the assignees closest to #6,659 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Halozyme's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Halozyme, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Halozyme ranks #474 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Oxylabs, UAB 54 Advanced Micro-fabrication Equipment Inc. China 54 Heatcraft Refrigeration Products LLC 54 Bayer Pharma Aktiengesellschaft 54

Similar claim depth

Nearest assignees by average claims per patent (29.3 here).

Agenus Inc. 29.4 avg Mexichem Fluor S.A. DE C.V. 29.4 avg The Reliable Automatic Sprinkler Co. Inc. 29.4 avg Qualcomm Incorporated 29.1 avg

Halozyme's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Halozyme, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	6.0%
2016	5	10.0%
2017	6	12.0%
2018	6	12.0%
2019	3	6.0%
2020	2	4.0%
2021	3	6.0%
2022	1	2.0%
2023	2	4.0%
2024	15	30.0%
2025partial year	4	8.0%

Which technologies does Halozyme, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 47

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 46

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 41

C12Y - Enzymes 39

Y02A - Technologies FOR Adaptation TO Climate Change 29

C07K - Peptides 24

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 23

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 20

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Halozyme, Inc.'s patent record in context - here's where to go next.

Halozyme, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 94% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #6,659 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Halozyme, Inc. against Gustav Klauke GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.